说明书变更的超说明书用法所致医疗机构法律风险分析Analysis of Medical Institutions Legal Risk Caused by Off-label Drug Use Due to Instruction Change
刘敏豪,黎颖怡
LIU Minhao,LI Yingyi
摘要(Abstract):
目的为应对因说明书变更而发生的超说明书用法所致医疗机构的法律风险提供建议。方法探讨超药品说明书用药的法律风险,分析相同成分、相同途径、不同厂家说明书间的差异以及说明书修改所致差异导致超药品说明书用法过程,提出超药品说明书用药的监控策略,望为应对相关问题提供思路。结果与结论设法杜绝说明书变更所致的超说明书用法,是医院药师责无旁贷的工作。
OBJECTIVE To provide advices in dealing with medical institutions legal risk caused by off-label drug use due to instruction change. METHODS To discuss the legal risk caused by off-label drug use due to instruction change. To analy the instructions differences in medicines of different manufactures. To analy the drug usage beyond the instructions result of the differences,due to modifying the instructions. Put forword the monitoring strategy to deal with the off-label drug use. RESULTS and CONCLUSION It is an unshirkable duty for hospital pharmacists to try to stop off-label drug use due to changes in instructions.
关键词(KeyWords):
超药品说明书用药;药品说明书;风险;对策
off-label drug use;instructions;risk;strategy
基金项目(Foundation):
作者(Author):
刘敏豪,黎颖怡
LIU Minhao,LI Yingyi
参考文献(References):
- [1]国家卫生和计划生育委员会.三级综合医院评审标准实施细则(卫医管发[2011]33号)[S].2011.
- [2]广东省药学会.超药品说明书用药目录(2016年版)[J].今日药学,2016,26(6):369-383.
- [3]刘敏豪,冼培愉,邬倩倩.30组同成分不同厂家口服药品说明书差异状况调查[J].中国药房,2013,24(34):3239-3241.
- [4]刘敏豪,李帼姬,邬倩倩.药品说明书“修改日期”项评价药品性能的应用研究[J].中国医院药学杂志,2015,35(14):1335-1339.
- [5]刘敏豪,邬倩倩.我院药品说明书现状调查及其相关风险分析[J].中国药房,2012,23(17):1619-1621.
- [6]中华人民共和国立法法(中华人民共和国主席令第20号)[S].2015.
- [7]国家卫生和计划生育委员会.处方药管理办法(中华人民共和国卫生部令第53号)[S].2006.
- [8]中华人民共和国侵权责任法(中华人民共和国主席令第21号)[S].2009.
- [9]国务院.医疗事故处理条例[S].2002.
- [10]中华人民共和国卫生部.药品不良反应报告和监测管理办法(卫生部令第81号)[S].2011.